IL15 and cancer: Intriguingly, in these S100a8-cre-Il15fl/flPyMT mice, the loss of cancer-cell derived IL-15 resulted in reduced αβILTCK recruitment into the tumour tissue and impaired cancer immunosurveillance, with accelerated tumour growth in comparison to wild-type controls.